Listed

Phio Pharmaceuticals Corp.: Form 10-Q for the period ended Jun 30, 2020

Filed with the SEC on Aug 12, 2020 and accepted by EDGAR at Aug 12, 2020, 17:00 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-04-01 to 2020-06-30$0us-gaap:Revenues
Revenue6 months2020-01-01 to 2020-06-30$0us-gaap:Revenues
Research and development3 months2020-04-01 to 2020-06-30$779.0kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2020-01-01 to 2020-06-30$2.0mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2020-04-01 to 2020-06-30−$1.7mus-gaap:OperatingIncomeLoss
Operating income6 months2020-01-01 to 2020-06-30−$4.0mus-gaap:OperatingIncomeLoss
Net income3 months2020-04-01 to 2020-06-30−$1.7mus-gaap:NetIncomeLoss
Net income6 months2020-01-01 to 2020-06-30−$4.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-04-01 to 2020-06-30−$0.34us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2020-01-01 to 2020-06-30−$1.19us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2020-01-01 to 2020-06-30−$4.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2020-01-01 to 2020-06-30$10.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-06-30$18.9mus-gaap:Cash
Current assetsAt period end2020-06-30$19.6mus-gaap:AssetsCurrent
Total assetsAt period end2020-06-30$20.2mus-gaap:Assets
Current liabilitiesAt period end2020-06-30$1.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-06-30$2.5mus-gaap:Liabilities
Long-term debtAt period end2020-06-30$231.0kus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2020-06-30$17.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001683168-20-002649. Last ingested by Listed: Nov 12, 2026, 20:44 ET. Listed shows no prices and gives no investment advice.